Rotavirus Gastroenteritis and Vaccine Usage in Rhode Island
1 other identifier
observational
803
1 country
1
Brief Summary
The goals of this study are to see what effects the introduction of RV5(RotaTeq) vaccine has had in the community both on the number of rotavirus-associated hospitalizations and on the strains of rotavirus circulating in the community. The investigators will use cases of rotavirus gastroenteritis identified on the wards at Hasbro Children's Hospital during the 2007-2009 rotavirus seasons for a case-control study to estimate rotavirus vaccine effectiveness in preventing rotavirus-associated hospitalizations. The investigators plan to assess rotavirus vaccine coverage in Rhode Island using the state vaccine registry and to examine whether and to what extent rotavirus vaccine was used outside the recommended age limits (off label) during the first 2 years of its implementation in Rhode Island. Finally using the state child health database, KIDSNET the investigators plan to investigate the reasons that children may not have received rotavirus vaccine in order to better target educational efforts for parents and health care providers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2009
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2009
CompletedFirst Submitted
Initial submission to the registry
December 2, 2009
CompletedFirst Posted
Study publicly available on registry
December 4, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2019
CompletedNovember 14, 2019
November 1, 2019
10.3 years
December 2, 2009
November 12, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rotavirus vaccine effectiveness in preventing rotavirus-associated hospitalizations
Rotavirus vaccine effectiveness in preventing rotavirus-associated hospitalizations under field conditions
2007-2009
Secondary Outcomes (4)
Vaccine use outside the recommended age limits
2007-2009
Risk factors for non-receipt of rotavirus vaccine
2007-2009
Characterize the strains of rotavirus circulating in the community
2002-2009
Assess rotavirus vaccine coverage
2007-2009
Study Arms (2)
Cases of rotavirus gastroenteritis
Patients will be eligible as cases if they have been identified by the investigator's ongoing rotavirus surveillance studies as having been hospitalized with laboratory-confirmed rotavirus gastroenteritis between January 1, 2007 and June 31, 2009. To be eligible as a case, the child must meet the following criteria: 1) immunocompetent; 2) born after April 15, 2006 (to select a population that would have been in the age group eligible for at least 1 dose of RV5 (RotaTeq); and 3) \> 2 months of age on the day of admission.
Control Subjects
Three controls for each case will be identified using KIDSNET, the state child health registry. Controls will be matched to cases by age and county of residence at birth.
Eligibility Criteria
Residents of Rhode Island
You may qualify if:
- rotavirus gastroenteritis requiring hospitalization
- immunocompetent
- born after April 15, 2006
- greater than 2 months of age on the day of admission
You may not qualify if:
- rotavirus vaccine contraindicated for that child based on ACIP/AAP recommendations
- an immunization record cannot be obtained through the KIDSNET database
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lifespanlead
- Merck Sharp & Dohme LLCcollaborator
Study Sites (1)
Hasbro Children's Hospital
Providence, Rhode Island, 02903, United States
Biospecimen
Stools
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Penelope H Dennehy, MD
Rhode Island Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 2, 2009
First Posted
December 4, 2009
Study Start
July 1, 2009
Primary Completion
November 1, 2019
Study Completion
November 1, 2019
Last Updated
November 14, 2019
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share IPD since the study uses a deidentified dataset and deidentified stool specimens for serotype analysis